Free Trial

Amylyx Pharmaceuticals (AMLX) Insider Trading & Ownership

Amylyx Pharmaceuticals logo
$4.27 -0.01 (-0.23%)
(As of 09:56 AM ET)

Amylyx Pharmaceuticals (NASDAQ:AMLX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.70%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$326,397.50
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$494,508.16
Get AMLX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Amylyx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AMLX Insider Buying and Selling by Quarter

Amylyx Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/30/2024Camille L BedrosianInsiderSell11,442$3.20$36,614.40  
9/30/2024Justin B KleeCEOSell18,589$3.20$59,484.80  
9/12/2024James M FratesCFOBuy40,000$2.53$101,200.00  
9/3/2024George M Milne JrDirectorBuy100,000$2.20$220,000.00  
5/15/2024Gina MazzarielloInsiderSell10,455$1.88$19,655.40  
5/14/2024Daphne QuimiDirectorBuy2,750$1.89$5,197.50  
3/5/2024Gina MazzarielloInsiderSell1,540$18.73$28,844.20  
3/5/2024James M FratesCFOSell1,792$18.73$33,564.16  
3/5/2024Joshua B CohenCEOSell4,135$18.73$77,448.55  
2/23/2024Gina MazzarielloInsiderSell2,838$18.76$53,240.88  
1/9/2024James M FratesCFOSell2,716$16.33$44,352.28  
1/9/2024Justin B KleeCEOSell5,841$16.33$95,383.53  
1/9/2024Patrick D YeramianInsiderSell2,812$16.33$45,919.96  
(Data available from 1/1/2013 forward)

AMLX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Amylyx Pharmaceuticals includes Camille L Bedrosian, Daphne Quimi, George M Milne Jr, Gina Mazzariello, Global Investors Lp Viking, James M Frates, Joshua B Cohen, Justin B Klee, Morningside Venture Investment, and Patrick D Yeramian. Learn more on insiders at AMLX.

11.70% of Amylyx Pharmaceuticals stock is owned by insiders. Learn more on AMLX's insider holdings.

The following insiders have purchased AMLX shares in the last 24 months: Daphne Quimi ($5,197.50), George M Milne Jr ($220,000.00), and James M Frates ($101,200.00).

Insiders have purchased a total of 142,750 AMLX shares in the last 24 months for a total of $326,397.50 bought.

The following insiders have sold AMLX shares in the last 24 months: Camille L Bedrosian ($36,614.40), George M Milne Jr ($1,116,150.00), Gina Mazzariello ($225,421.62), James M Frates ($1,989,891.44), Joshua B Cohen ($77,448.55), Justin B Klee ($3,340,868.33), Morningside Venture Investment ($10,931,921.94), and Patrick D Yeramian ($3,648,369.06).

Insiders have sold a total of 715,213 Amylyx Pharmaceuticals shares in the last 24 months for a total of $21,366,685.34 sold.

Amylyx Pharmaceuticals Key Executives

  • Mr. Joshua B. Cohen (Age 32)
    Co-Founder, Co-CEO & Director
    Compensation: $1.08M
  • Mr. Justin B. Klee (Age 33)
    Co-Founder, Co-CEO & Director
    Compensation: $1.08M
    1 recent trades
  • Mr. James M. Frates M.B.A. (Age 57)
    Chief Financial Officer
    Compensation: $763.16k
    1 recent trades
  • Ms. Gina M. Mazzariello (Age 53)
    Chief Legal Officer & General Counsel
    Compensation: $689.26k
  • Dr. Camille L. Bedrosian M.D. (Age 71)
    Chief Medical Officer
    Compensation: $232.6k
    1 recent trades
  • Mr. Tom Holmes
    Chief Technical Operations Officer
  • Lindsey Allen
    Head of Investor Relations & Communications
  • Ms. Shauna Horvath
    Head of Global Marketing
  • Ms. Linda A. Arsenault
    Chief Human Resources Officer
  • Mr. Chris Aiello
    Head of Canada & GM


This page (NASDAQ:AMLX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners